Dayvigo release date?

See the DrugPatentWatch profile for Dayvigo

When did Dayvigo (lemborexant) first get approved and launched?

Dayvigo (lemborexant) was approved by the U.S. Food and Drug Administration (FDA) in 2019. Exact “release date” depends on whether you mean FDA approval date versus the first commercial availability date in the U.S. market.

What is the FDA approval date for Dayvigo?

Dayvigo’s FDA approval came in 2019, making it a relatively recent prescription sleep medicine. If you’re looking for the specific approval day (month/day/year), the most reliable way is to check the FDA approval announcement and label history for the first marketed product.

When could it become available internationally?

Commercial availability outside the U.S. typically follows later national approvals and local launch timelines, which can differ by country even if the global development was the same.

Where to check the most precise “first availability” timing?

For patent and launch-related timing that may help pinpoint when Dayvigo entered the market, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/

Quick clarification (so I can give the exact date you want)

Do you mean:
1) the FDA approval date (month/day/year), or
2) the first date pharmacies started stocking it (first commercial launch date in the U.S.)?